retatrutide triple hormone receptor agonist mechanism of action vs Survodutide: vs Dual Comparison for Obesity and MASH - Which Is Better? | PPW How Does Retatrutide Work? Doctor

Full article linked below.

Objective The aim was to compare the risk of incident AF after initiation of GLP-1RAs versus dipeptidyl peptidase-4 inhibitors (DPP4is), as active comparators, in patients with DM

Yes, this 44-year-old woman with a history of papillary thyroid carcinoma (PTC) resected 10 years ago is an excellent candidate for GLP-1 receptor agonist th...

Diabetes mellitus (DM) is a metabolic disorder associated with cognitive impairment

ATTAIN-1 Trial Highlights: - Mean weight loss of ~12.4% over 72 weeks for patients on the highest dose - Participants lost an average of 25 pounds (11.1%) regardless of trial completion - Safety profile consistent with GLP-1 class